Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

1.18
Delayed Data
As of 3:58pm ET
 +0.01 / +0.85%
Today’s Change
0.81
Today|||52-Week Range
3.48
-10.61%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.17
Today’s open1.18
Day’s range1.15 - 1.21
Volume34,141
Average volume (3 months)153,369
Market cap$29.7M
Dividend yield--
Data as of 3:58pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+40.42%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...-0.05-2.16%
FCSCFibrocell Science In...0.000.00%
ADHDAlcobra Ltd+0.04+3.64%
CERUCerulean Pharma Inc-0.38-33.93%
Data as of 3:59pm ET, 03/23/2017

Financials

Last reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Larry M. Dillaha
CFO, Secretary &
Chief Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts


Search for Jobs